Quick links to products
The VenaSeal closure system (VenaSeal system) is indicated for use in the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation. The VenaSeal system is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (DUS).
Separate use of the individual components of the VenaSeal closure system is contraindicated. These components must be used as a system. The use of the VenaSeal system is contraindicated when any of the following conditions exist: previous hypersensitivity reactions to the VenaSeal™ adhesive or cyanoacrylates, acute superficial thrombophlebitis, thrombophlebitis migrans, acute sepsis.
The potential adverse effects (e.g., complications) associated with the use of the VenaSeal system include, but are not limited to, adverse reactions to a foreign body (including, but not limited to, nonspecific mild inflammation of the cutaneous and subcutaneous tissue), arteriovenous fistula, bleeding from the access site, deep vein thrombosis (DVT), edema in the treated leg, embolization, including pulmonary embolism (PE), hematoma, hyperpigmentation, hypersensitivity or allergic reactions to cyanoacrylates, such as urticaria, shortness of breath, and anaphylactic shock, infection at the access site, pain, paresthesia, phlebitis, superficial thrombophlebitis, urticaria, erythema, or ulceration may occur at the injection site, vascular rupture and perforation, visible scarring.
Instructions for use can be found in the product labeling at manuals.medtronic.com.
Caution: Federal (United States) law restricts these devices to sale by or on the order of a physician.
The ClosureFast™ radiofrequency ablation (RFA) catheter is intended for endovascular coagulation of blood vessels in patients with superficial vein reflux.
The ClosureFast catheter is contraindicated for use in patients with thrombus in the target vein segment.
The potential complications include, but are not limited to, the following: adjacent nerve injury, hematoma, pulmonary embolism, thrombosis, infection, phlebitis, skin burn or discoloration, and vessel perforation.
Important: Please reference the Instructions For Use (IFU) for a complete listing of indications, contraindications, warnings and precautions, adverse effects, and suggested procedure.
The ClosureRFS™ stylet is intended for use in vessel and tissue coagulation, including treatment of incompetent (i.e., refluxing) perforator and tributary veins.
The ClosureRFS stylet is contraindicated for use in patients with thrombus in the vein segment to be treated.
The potential complications include, but are not limited to, the following: arteriovenous fistula, infection, phlebitis, skin burns, hematoma, nerve damage, pulmonary embolism, and thrombosis.
The ClosureRFG generator is used with radiofrequency catheters intended for vessel and tissue coagulation.
Refer to the applicable radiofrequency catheter instructions for use for a list of contraindications related to a ClosureFast system procedure.
Refer to the applicable radiofrequency catheter instructions for use for a list of potential complications related to a ClosureFast system procedure.
Important: Please reference to the Operation Manual for a complete listing of indications, warnings, precautions, safety notices, and operational information.
UC201907929-01cEN
Find more information, including other available configurations, for VenaSeal™ closure system.
Your information will be used and protected in accordance with our {link}
Hours: 8:00 a.m. - 8:00 p.m. EST
Phone: 763-514-4000
Toll-free: 800-633-8766
Just to confirm, is this the product or product type that interests you?
{{productNamePlaceholder}}
OR
Before we get started, what best describes you?
If you subscribe to email updates, you can unsubscribe anytime via the link in each email. We use technology to measure email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}
Your personal data will be used to manage your relationship with Medtronic in accordance with our {link}
If you consent to receive emails, you can unsubscribe anytime via the link in each email. We use technology that measures email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}
